Repetitive transcranial magnetic stimulation (rTMS/dTMS) for major depressive disorder
Defines medical necessity, investigational indications, prior authorization, coding, and contraindications for rTMS/dTMS using FDA-cleared devices for Commercial and Medicare members of Blue Cross Blue Shield Massachusetts.
Prior authorization is required on codes 90867, 90868, 90869.
Annual policy review with updates to description, summary, and references; policy statements unchanged.
Policy clarified to include prior authorization requests using Authorization Manager.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.